Aspire Biopharma Holdings, Inc. - Common Stock (ASBP)

25 filings reported holding ASBP - Aspire Biopharma Holdings, Inc. - Common Stock as of Q2 2025.
Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,044,304 shares of 48,847,035 outstanding shares and own 4.19% of the company stock.
Largest 10 shareholders include Procyon Advisors, LLC (648,411 shares), Crewe Advisors LLC (626,854 shares), Optivise Advisory Services LLC (235,106 shares), JANE STREET GROUP, LLC (152,552 shares), VR Advisory Services Ltd (97,391 shares), Three Seasons Wealth, LLC (75,000 shares), Periscope Capital Inc. (75,000 shares), VALLEY WEALTH MANAGERS, INC. (40,000 shares), Platform Technology Partners (37,611 shares), and GOLDMAN SACHS GROUP INC (18,701 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.